BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38459154)

  • 1. Transformation risk and associated survival outcome of marginal zone lymphoma: A nationwide study.
    Sun X; Li H; Yang Y; Wu Y; Kang K; Liu Q; Luo R; Wang L; Zhao A; Niu T
    Ann Hematol; 2024 Mar; ():. PubMed ID: 38459154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation to diffuse large B-cell lymphoma and its impact on survival in patients with marginal zone lymphoma: A population-based study.
    Du Y; Wang Y; Li Q; Chang X; Shen K; Zhang H; Xiao M; Xing S
    Int J Cancer; 2024 Mar; 154(6):969-978. PubMed ID: 37874120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transformation and survival in marginal zone lymphoma: a Finnish nationwide population-based study.
    Kalashnikov I; Tanskanen T; Viisanen L; Malila N; Jyrkkiö S; Leppä S
    Blood Cancer J; 2023 Apr; 13(1):62. PubMed ID: 37185610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion 20q12 is associated with histological transformation of nodal marginal zone lymphoma to diffuse large B-cell lymphoma.
    Qian L; Soderquist C; Schrank-Hacker A; Strauser H; Dupoux V; Tang CN; Smith JR; Sun A; Majumdar S; Nguyen T; Widura S; Landsburg DJ; Schuster SJ; Baxter RHG; Bogusz AM
    Am J Hematol; 2020 Mar; 95(3):238-244. PubMed ID: 31804739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Characteristics, Treatment and Evolution of Splenic and Nodal Marginal Zone Lymphomas-Retrospective and Multicentric Analysis of Portuguese Centers.
    Rodrigues CD; Peixeiro RP; Viegas D; Chorão P; Couto ME; Gaspar CL; Fernandes JP; Alves D; Ribeiro LA; de Vasconcelos M P; Tomé AL; Badior M; Coelho H; Príncipe F; Chacim S; da Silva MG; Coutinho R
    Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):e839-e844. PubMed ID: 34326035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of Marginal Zone Lymphoma.
    Cerhan JR; Habermann TM
    Ann Lymphoma; 2021 Mar; 5():. PubMed ID: 33829216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO.
    Avivi I; Arcaini L; Ferretti VV; Boumendil A; Finel H; Milone G; Zaja F; Liliana D; Musso M; Didier B; Bachy E; Wattad M; Nicolas-Virelizier E; Gramatzki M; Bourhis JH; Caillot D; Haenel A; Held G; Thieblemont C; Jindra P; Pohlreich D; Guilhot F; Kroschinsky F; Wahlin B; Scheid C; Ifrah N; Berthou C; Dreger P; Montoto S; Conconi A
    Br J Haematol; 2018 Sep; 182(6):807-815. PubMed ID: 29984825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A population-based study of transformed marginal zone lymphoma: identifying outcome-related characteristics.
    Bult JAA; Huisman F; Zhong Y; Veltmaat N; Kluiver J; Tonino SH; Vermaat JSP; Chamuleau MED; Diepstra A; van den Berg A; Plattel WJ; Brink M; Nijland M
    Blood Cancer J; 2023 Sep; 13(1):130. PubMed ID: 37658062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database.
    Olszewski AJ; Castillo JJ
    Cancer; 2013 Feb; 119(3):629-38. PubMed ID: 22893605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marginal zone lymphoma: old, new, targeted, and epigenetic therapies.
    Joshi M; Sheikh H; Abbi K; Long S; Sharma K; Tulchinsky M; Epner E
    Ther Adv Hematol; 2012 Oct; 3(5):275-90. PubMed ID: 23616915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical history, lifestyle, family history, and occupational risk factors for marginal zone lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.
    Bracci PM; Benavente Y; Turner JJ; Paltiel O; Slager SL; Vajdic CM; Norman AD; Cerhan JR; Chiu BC; Becker N; Cocco P; Dogan A; Nieters A; Holly EA; Kane EV; Smedby KE; Maynadié M; Spinelli JJ; Roman E; Glimelius B; Wang SS; Sampson JN; Morton LM; de Sanjosé S
    J Natl Cancer Inst Monogr; 2014 Aug; 2014(48):52-65. PubMed ID: 25174026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of Upfront Therapy for Marginal Zone Lymphoma.
    Ortega JL; Cabanillas F; Rivera N; Tirado-Gomez M; Hallman D; Pardo WI; Bruno M
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):879-883. PubMed ID: 29042174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenic Marginal Zone Lymphoma With Histological Transformation to Hodgkin's Lymphoma.
    Veeraballi S; Mirza N; Khawar Z; Shaaban H
    Cureus; 2022 Jul; 14(7):e26738. PubMed ID: 35967131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of 487 patients with early-stage extra-nodal marginal zone lymphoma.
    Teckie S; Qi S; Chelius M; Lovie S; Hsu M; Noy A; Portlock C; Yahalom J
    Ann Oncol; 2017 May; 28(5):1064-1069. PubMed ID: 28327924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles.
    Arcaini L; Paulli M; Boveri E; Vallisa D; Bernuzzi P; Orlandi E; Incardona P; Brusamolino E; Passamonti F; Burcheri S; Schena C; Pascutto C; Cavanna L; Magrini U; Lazzarino M
    Cancer; 2004 Jan; 100(1):107-15. PubMed ID: 14692030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nodal monocytoid B-cell lymphoma (nodal marginal-zone B-cell lymphoma).
    Nathwani BN; Drachenberg MR; Hernandez AM; Levine AM; Sheibani K
    Semin Hematol; 1999 Apr; 36(2):128-38. PubMed ID: 10319381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transformation of marginal zone lymphoma (and association with other lymphomas).
    Casulo C; Friedberg J
    Best Pract Res Clin Haematol; 2017; 30(1-2):131-138. PubMed ID: 28288708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare lymphomas in routine practice - Treatment and outcome in marginal zone lymphoma in the prospective German Tumour Registry Lymphatic Neoplasms.
    Knauf W; Abenhardt W; Koenigsmann M; Maintz C; Sandner R; Zahn MO; Schnell R; Tech S; Kaiser-Osterhues A; Houet L; Marschner N;
    Hematol Oncol; 2021 Aug; 39(3):313-325. PubMed ID: 33942348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary management of nodal and primary splenic marginal zone lymphoma.
    Leslie LA; Feldman TA; McNeill A; Timberg M; Iida H; Goy AH
    Expert Rev Hematol; 2019 Dec; 12(12):1011-1022. PubMed ID: 31619091
    [No Abstract]   [Full Text] [Related]  

  • 20. Trends in incidence, therapy and outcome of localized nodal and extranodal marginal zone lymphomas: declining incidence and inferior outcome for gastrointestinal sites.
    Kuper-Hommel MJ; van de Schans SA; Vreugdenhil G; van Krieken JH; Coebergh JW
    Leuk Lymphoma; 2013 Sep; 54(9):1891-7. PubMed ID: 23302044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.